Publication date: Feb 03, 2020 Immune-related adverse events are associated with a longer recurrence-free survival in patients with stage III melanoma treated with pembrolizumab. In this secondary analysis of a ... Read more

Publication date: Feb 08, 2020 Circulating tumor cells appeared independently associated with relapse among patients with stage III melanoma, according to results of a prospective study published in Clinical Cancer ... Read more

Publication date: Feb 06, 2020 PET and other radiologic surveillance such as computed tomography scans are frequently used for melanoma recurrence testing after treatment. Concepts Keywords Biopsy Tomography Computed Tomography ... Read more

Publication date: Feb 04, 2020 Levels of circulating tumor cells (CTCs), measured by liquid biopsy, were independently associated with relapse in patients with stage III melanoma, . .. Concepts Keywords ... Read more